发明授权
US09562051B2 Methylenedioxybenzo [I] phenanthridine derivatives used to treat cancer
有权
用于治疗癌症的亚甲二氧基苯并[I]菲啶衍生物
![Methylenedioxybenzo [I] phenanthridine derivatives used to treat cancer](/docs/US/2017-02-07/US09562051B2/abs.jpg.600x600.jpg)
- 专利标题： Methylenedioxybenzo [I] phenanthridine derivatives used to treat cancer
- 专利标题（中）： 用于治疗癌症的亚甲二氧基苯并[I]菲啶衍生物
-
申请号： US13255081申请日： 2010-03-05
-
公开(公告)号： US09562051B2公开(公告)日： 2017-02-07
- 发明人: Edmond J. LaVoie , Wei Feng , Leroy F. Liu
- 申请人： Edmond J. LaVoie , Wei Feng , Leroy F. Liu
- 申请人地址： US NJ New Brunswick
- 专利权人： Rutgers, the State University of New Jersey
- 当前专利权人： Rutgers, the State University of New Jersey
- 当前专利权人地址： US NJ New Brunswick
- 代理机构： Viksnins Harris & Padys PLLP
- 国际申请： PCT/US2010/026381 WO 20100305
- 国际公布： WO2010/102219 WO 20100910
- 主分类号： C07D491/04
- IPC分类号： C07D491/04 ; A61K31/4355
![Methylenedioxybenzo [I] phenanthridine derivatives used to treat cancer](/abs-image/US/2017/02/07/US09562051B2/abs.jpg.150x150.jpg)
摘要：
The invention provides compounds of formula I: wherein A, B, X, and Y have any of the values defined in the specification, as well as pharmaceutical compositions comprising such compounds, processes for preparing such compounds, and therapeutic methods for treating cancer and other topoisomerase mediated conditions.
公开/授权文献
信息查询
